Huiyu Pharmaceutical(SH:688553) Xin Lang Cai Jing·2025-10-31 03:27Core Viewpoint - Huayu Pharmaceutical's stock increased by 5.03% on October 31, reaching 21.30 CNY per share, with a total market capitalization of 9.023 billion CNY [1] Company Overview - Sichuan Huayu Pharmaceutical Co., Ltd. was established on October 12, 2010, and listed on October 26, 2021. The company focuses on the research, production, and sales of drugs in the oncology field and complex injectable drugs [1] - The main revenue composition includes 97.27% from drug sales, 1.66% from technical services, and 1.07% from other sources [1] Shareholder Information - Ping An Fund's Ping An Medical Health Mixed A (003032) entered the top ten circulating shareholders of Huayu Pharmaceutical in the third quarter, holding 6.8378 million shares, which is 1.99% of the circulating shares [2] - The estimated floating profit from this investment is approximately 6.9746 million CNY [2] Fund Performance - Ping An Medical Health Mixed A (003032) was established on November 24, 2017, with a current size of 2.028 billion CNY. The fund has achieved a year-to-date return of 56.7%, ranking 794 out of 8154 in its category [2] - Over the past year, the fund's return is 47.82%, ranking 1222 out of 8046, and since inception, it has returned 143.53% [2]